Expression of cadherin 17 in well‐differentiated neuroendocrine tumours

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|66|7|1010-1021

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.66, Iss.7, 2015-06, pp. : 1010-1021

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Status and Perspectives of Targeted Therapy in Well-Differentiated Neuroendocrine Tumors

By  

Oncology, Vol. 83, Iss. 3, 2012-07 ,pp. : 117-127

Karger

Access to resources Recommend Favorite

Well-Differentiated Grade 2, Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-04 ,pp. : 255-261

Karger

Access to resources Recommend Favorite

Long-Term Management of a Patient with Well-Differentiated Pulmonary Neuroendocrine Carcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-04 ,pp. : 209-215

Karger

Access to resources Recommend Favorite

Acute Tumor Lysis Syndrome after Transarterial Chemoembolization for Well-Differentiated Hepatocellular Carcinoma with Neuroendocrine Features

By  

Oncology Research and Treatment, Vol. 33, Iss. 10, 2010-09 ,pp. : 532-535

Karger

Access to resources Recommend Favorite

Cadherin 17 is frequently expressed by ‘sclerosing variant’ pancreatic neuroendocrine tumour

By  

HISTOPATHOLOGY, Vol. 66, Iss. 2, 2015-01 ,pp. : 225-233

John Wiley & Sons Inc

Access to resources Recommend Favorite